Cart
sales@molnova.com
BL-AD008
CAS No. ——
BL-AD008( BL-AD 008 )
Catalog No. M17014 CAS No. ——
BL-AD008 (BL-AD 008) is a novel small molecule, dual-target activator targeting AMPK/ZIPK.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBL-AD008
-
NoteResearch use only, not for human use.
-
Brief DescriptionBL-AD008 (BL-AD 008) is a novel small molecule, dual-target activator targeting AMPK/ZIPK.
-
DescriptionBL-AD008 (BL-AD 008) is a novel small molecule, dual-target activator targeting AMPK/ZIPK; demonstrates remarkable anti-proliferative activities toward cervical cancer cells and could induce apoptosis by death-receptor and mitochondrial pathways; also shows anti-tumor activities and induces apoptosis by targeting AMPK/ZIPK in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsBL-AD 008
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorAMPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight501.045
-
Molecular FormulaC28H25ClN4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(Z)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-3-benzylidene-6-chloroindolin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fu L, et al. Oncotarget. 2015 Apr 10;6(10):8071-88.
molnova catalog
related products
-
Aldometanib
Aldometanib (LXY-05-029) is an orally active aldolase inhibitor that prevents FBP from binding to v-ATPase-associated aldolase and activates lysosomal AMPK, useful in metabolic homeostasis research .
-
Ampkinone
Ampkinone is a novel small molecule activator of AMPK, stimulates the phosphorylation of AMPK via indirect activation of AMPK in various cell lines.
-
Kahweol
Kahweol has anticarcinogenic, anti-angiogenic,and anti-inflammatory activities.
